This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Philips Respironics CoughAssist T70 Airway Clearance Technology -- An Effective Alternative To Traditional Suctioning Methods

MURRYSVILLE, Pa., Jan. 8, 2013 /PRNewswire/ -- Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHIA), today announced that it has received 510(k) clearance to market its latest advancement in airway clearance technology for enhanced patient care in the hospital or in the home. The new CoughAssist T70 provides an effective, comfortable alternative to traditional suctioning methods and may minimize the risk of pneumonia and infections that can lead to hospital readmissions.

To view the multimedia assets associated with this release, please click:

(Photo: )

"Philips Respironics is dedicated to providing patients, their caregivers and clinical teams with innovative solutions that improve patient care," said Jay Vreeland, director, North American marketing, home respiratory, Philips Home Healthcare Solutions. "The CoughAssist T70 couples clinically-proven technology with evolutionary enhancements that make it simpler to operate, conveniently flexible and more sensitive to the user's breathing pattern for a more natural treatment."   

The CoughAssist T70 next generation device incorporates proven technology that's effective, and easy to use. It clears secretions from the lungs by gradually applying positive air pressure to the airway and then rapidly shifting to negative air pressure. The shift in pressure creates a high expiratory flow that simulates a deep, natural cough. Instead of introducing a suction catheter into the airway, air is delivered through a facemask, a mouthpiece or through a simple adapter that allows the device to function with an endotracheal or tracheostomy tube, reducing discomfort and risk of infection. In addition, new design and technology updates have been developed to enhance patient and clinician use.
  • Cough-Trak – A unique triggering feature with automatic sensitivity allows patients to initiate therapy and synchronize treatment with their own breathing pattern;
  • Portability – Weighing less than 9 lbs., it is compact, lightweight and easy to transport;
  • Flexibility – In addition to AC and DC power options, a detachable lithium ion battery allows up to four treatments on a single charge;
  • Ease of use –  A user-friendly digital interface and preset prescriptions simplify setup and initiating therapy;
  • Results – New data management software allows patients and caregivers to monitor tidal volume, peak cough flow and oxygen saturation levels to enhance therapy effectiveness.

The CoughAssist T70 comes with an SD card, hose clip, air filter, patient circuit, adult mask, carrying case, and AC power cord.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,882.14 +162.22 0.92%
S&P 500 2,089.89 +9.48 0.46%
NASDAQ 5,127.2090 +18.5430 0.36%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs